| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Studies the chemical properties, reactions, folding, stability, interactions, and modifications of proteins; excludes gene-expression processes unless directly tied to protein structure/function, and excludes purely metabolic pathways without protein-chemistry focus. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates from atomic-level bonding and side-chain chemistry to secondary/tertiary/quaternary structure, protein complexes, aggregation behavior, and cellular protein networks. |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Amino acids, peptides, proteins, domains, motifs, disulfide bonds, side chains, post-translational modifications (PTMs), cofactors, folding intermediates, aggregates, protein complexes, chaperones. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Charge, hydrophobicity, pKa values, stereochemistry, stability (ΔG_fold), solubility, reactivity, redox state, conformational flexibility, aggregation propensity, binding affinity, modification state. |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Structural classes (fibrous, globular, membrane proteins), functional classes (enzymes, receptors, transporters), PTM categories (phosphorylation, glycosylation, ubiquitination), peptide classes, folding types, oligomerization states. |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | pH, temperature, ionic strength, redox environment, PTM occupancy, ligand concentration, folding/unfolding state, conformational ensemble, oligomerization state, solvent polarity, denaturant concentration. |
| | Parameterization | How variables encode and represent the system’s state. | States encoded via ΔG_fold values, melting temperature (Tm), RMSD/Rg, hydrogen-bond counts, reaction rate constants, binding constants (Kd), PTM stoichiometry, hydrophobicity scales, charge distributions, secondary-structure content. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating proteins as static structures, ignoring long-timescale dynamics, assuming ideal two-state folding, ignoring solvent or crowding effects, modeling only backbone atoms, assuming uniform side-chain behavior. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Valid for small, stable, well-folded proteins under defined conditions; breaks down for intrinsically disordered proteins (IDPs), membrane proteins, large complexes, aggregation-prone proteins, or crowded cellular environments. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Protein behavior arises from amino-acid chemistry; folding follows physicochemical rules; noncovalent interactions (H-bonding, hydrophobic effect, electrostatics) govern structure and stability; side-chain chemistry drives reactivity. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes reliable mapping from sequence → structure → behavior; stable residue identity; transferable hydrophobic/hydrophilic behavior; consistent PTM effects; consistent physical laws across protein families. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | Requires agreement among folding thermodynamics, chemical reactivity, side-chain ionization, PTM effects, structural models, and experimental evidence without contradictions. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Demands alignment between protein chemistry, structural biochemistry, enzymology, cellular biochemistry, and thermodynamic constraints within a unified chemical–biological framework. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Absorbance/fluorescence changes, circular dichroism signals, unfolding transitions, UV/visible spectra, NMR chemical shifts, MS peptide masses/fragments, SDS-PAGE band patterns, aggregation/turbidity, enzymatic activity shifts, PTM signatures. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Limited by protein concentration, signal-to-noise, spectral overlap, MS ionization efficiency, dynamic range, incomplete digestion, weak CD signals, low PTM abundance, probe sensitivity, and aggregation-induced scattering. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | Absorbance (a.u.), fluorescence intensity (a.u.), CD ellipticity (mdeg), mass-to-charge (m/z), concentration (µM–mM), melting temperature (°C), kinetic rates (s⁻¹), binding affinity (Kd), RMSD (Å), peptide coverage (%). |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | UV–Vis spectrophotometers, fluorimeters, CD spectrometers, NMR spectrometers, mass spectrometers (ESI, MALDI), HPLC/UPLC systems, SDS-PAGE rigs, calorimeters (DSC/ITC), FTIR, DLS, AFM, electron microscopes. |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Folding determined via thermal/chemical-unfolding curves; PTMs defined by mass shifts or antibody detection; aggregation defined by light scattering/turbidity; activity defined by substrate turnover; purity defined by gel or chromatogram. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | Protein extraction, purification, dialysis, concentration measurement, denaturation/renaturation assays, proteolytic digestion, chromatography workflows, labeling reactions, unfolding/refolding protocols. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Time-course unfolding/refolding scans, MS/MS fragmentation sequences, spectral scans (CD, fluorescence, NMR), chromatographic runs, gel electrophoresis imaging, calorimetric titration steps, aggregation time courses. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Replicate purifications, replicate spectra, multiple denaturation curves, peptide-level replicates, cross-batch protein samples, replicates for kinetics/activity assays, time-series sampling of folding intermediates. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | Spectra (UV–Vis, fluorescence, CD, IR), NMR FID and chemical shift tables, MS spectra/fragment maps, chromatograms, electrophoretic gels, DSC/ITC thermograms, DLS size distributions, unfolding curves. |
| | Resolution | The granularity or precision with which data is captured. | Determined by instrument sensitivity, spectral bandwidth, MS mass accuracy, NMR field strength, detector precision, gel resolution, temperature-control accuracy, and peptide fragmentation coverage. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Wavelength and detector calibration, MS mass-axis calibration, NMR field-locking and referencing, CD baseline calibration, calorimeter calibration, pipette/balance calibration, extinction coefficient verification. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Noise, drift, protein degradation, aggregation artifacts, incomplete digestion, ion suppression, spectral overlap, misassigned peaks, sample inhomogeneity, temperature instability, gel-loading variability. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Hydrophobic collapse drives folding; hydrogen-bonding defines secondary structure; disulfide formation stabilizes tertiary structure; electrostatic complementarity guides binding; sequence motifs predict structural motifs; PTMs alter stability/function in predictable patterns. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Conserved backbone geometry (Ramachandran constraints), invariant α-helix and β-sheet hydrogen-bonding patterns, conserved catalytic residues in protein families, stable side-chain ionization behaviors, recurring folding topologies (e.g., Rossmann, β-barrel). |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Noncovalent interactions control folding; chaperone-mediated folding pathways; covalent modification cycles; redox control of disulfides; ligand-induced conformational changes; cooperative unfolding; aggregation pathways (amyloid formation). |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Folding/unfolding trajectories, chaperone-assisted pathways, PTM addition/removal cycles, proteolytic processing, disulfide rearrangement pathways, aggregation → oligomer → fibril sequences, ligand-binding conformational-shift cycles. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Hydrophobic effect, secondary structure, tertiary/quaternary structure, motifs/domains, conformational ensemble, ΔG_fold, melting temperature, cooperativity, allostery, PTMs, binding affinity, chemical reactivity of side chains. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Protein structural classes (all-α, all-β, α/β, α+β), domain families, fold types, oligomeric states, PTM classes, enzyme classes (chemical reactivity), IDPs vs structured proteins, aggregation-prone vs stable proteins. |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | Folding thermodynamics: ΔG = ΔH − TΔS; two-state folding kinetics; Henderson–Hasselbalch for side-chain ionization; Hill equations for cooperative transitions; binding isotherms (Kd equations); Arrhenius/transition-state equations for side-chain reactivity. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | Energy-landscape models (folding funnels), molecular-dynamics models, coarse-grained folding models, homology models, secondary-structure prediction models, PTM-modification models, reaction-mechanism models for side-chain chemistry. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Perfect two-state folding; rigid tertiary structure; backbone-only models; neglect of solvent and crowding; uniform side-chain rotamers; no misfolding; isolated proteins with no quaternary interactions; linear PTM effects. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Fail for IDPs, multi-domain dynamics, extreme pH or denaturant environments, heavily modified proteins, membrane proteins, aggregation-prone systems, crowded intracellular environments, or non-two-state folding mechanisms. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Integration of chemical reactivity, folding thermodynamics, structural biology, PTM cycles, and ligand-binding energetics into unified models explaining how sequence → structure → chemistry → function emerges. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Connects to enzymology, structural biochemistry, medicinal chemistry, cellular biochemistry, systems biology, biotechnology (protein engineering), immunology (antibody structure), and nanotechnology (protein-based materials). |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Controlling pH, temperature, ionic strength, denaturants (urea/GdnHCl), ligand concentrations, redox state, PTM enzymes, proteases, salt concentration, and solvent polarity to test hypotheses about folding, stability, reactivity, and interactions. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Monitoring spontaneous unfolding, aggregation, autoxidation, disulfide reshuffling, spontaneous PTM turnover, baseline fluorescence/absorbance drift, and passive conformational fluctuations without imposed perturbation. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Comparing predicted folding curves, PTM effects, reactivity profiles, aggregation propensity, binding affinities, and stability changes with experimental outcomes from CD, DSC, MS, NMR, kinetics assays, and binding assays. |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Repeating unfolding/refolding scans, activity assays, MS digests, NMR experiments, chromatographic separations, SDS-PAGE runs, calorimetry scans, and binding titrations across technical and biological replicates. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Calculating ΔG_fold, Tm, kinetic rate constants, cooperativity parameters, binding affinities (Kd), PTM stoichiometry, aggregation rates, NMR chemical-shift changes, and uncertainty ranges for structural/chemical parameters. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Evaluating two-state vs multi-state folding models, cooperative vs non-cooperative transitions, different binding models (1:1, Hill, allosteric), alternative reaction mechanisms, and competing PTM-interpretation models. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying noise, baseline drift, incomplete denaturation, sample degradation, protease contamination, inaccurate extinction coefficients, MS ion suppression, misassigned peaks, temperature-control instability, and aggregation artifacts. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Blinding sample identity, randomizing run order, validating protein concentration, verifying probe labeling, normalizing buffer conditions, controlling for batch effects, using internal/external standards, and confirming results by orthogonal methods. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Independent evaluation of folding models, PTM assignments, MS peptide maps, structural interpretations, kinetic fits, and aggregation claims; cross-validation using different instruments and techniques. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Updating folding or binding models, revising mechanistic interpretations, correcting PTM assignments, adjusting thermodynamic parameters, redefining structural motifs, and integrating new multi-technique evidence. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full reporting of protein prep methods, buffer compositions, calibration curves, extinction coefficients, raw spectra, chromatograms, MS fragmentation tables, kinetic-fitting methods, and any limitations of stability/reactivity measurements. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Honest reporting of sample instability, aggregation, negative results, low-confidence PTM calls, uncertain structural fits, contamination issues, and adherence to biosafety and data-integrity standards. |